Crohn disease (CD) exhibits a 2-4-fold increased frequency in Jews as compared with other ethnic/racial groups. Three coding variants of the NOD2/CARD15 have been reported as independent disease-predisposing mutations (DPMs), but these were found in only 30%-40% of patients with CD and could not account for all the linkage between CD and the IBD1 locus. The aim of the present study was to explore whether additional DPMs at the IBD1 locus exist in the high-risk Jewish group. Sixty-four Ashkenazi Jewish and 147 non-Jewish white families were studied. Six microsatellite markers spanning IBD1 were genotyped for linkage analysis in subgroups stratified on NOD2/CARD15 DPM status. SNPs in NOD2/CARD15 (R702W, G908R, 1007fs, and S268P) were then genotyped in family and independent case-control samples. ) and the highest population-attributable P p .0005 risk (15.1%) for CD among reported DPMs in Jews. In Ashkenazi Jews, unrecognized population-specific predisposing factor(s) exist on the 268S-JW1 haplotype at the IBD1 locus. This factor may contribute to the higher risk for CD in Ashkenazi Jews as compared with non-Jews.
Introduction
Crohn disease (CD [MIM 266600]) is one of the two major forms of chronic inflammatory bowel disease (IBD) and can affect any part of the gastrointestinal tract. The cumulative risk of surgical treatment for patients with CD reaches 60% in 10 years after onset because of the fistulizing, perforating, stricturing, and/or obstructing complications of CD, thereby severely affecting patients' quality of life.
Although the pathogenesis of CD has not been fully elucidated, CD appears to be a multifactorial/oligogenic disease, with both environmental and genetic factors contributing to its etiology. The role of genetic factors in the etiology of CD has been supported by studies of ethnic differences, familial aggregation, and twin and spouse data (Yang and Rotter 2000) . With regard to ethnic variation, a consistently increased incidence (2.0-4.0 times) and prevalence rate (2.2-9.4 times) of CD in the Jewish population have been documented, compared with other ethnic groups in the same geographic area (Rotter et al. 1992 ). These observations are considered to be evidence for a strong genetic predisposition to the etiology of CD and have led to the hypothesis that the higher risk of CD in the Jewish population is due, at least in part, to genetic factors. Hugot et al. (1996) mapped the IBD1 gene to the proximal region of the long arm of chromosome 16 (16q12) in the white population, utilizing genomewide scan linkage strategies. This finding has been replicated in many studies, including an international collaborative study reporting a remarkably high multipoint linkage score (MLS) for a complex disease ( at MLS p 5.7 marker D16S411 in 16q12) (Ohmen et al. 1996; Parkes et al. 1996; Cho et al. 1997; Brant et al. 1998; Cavanaugh et al. 1998; Curran et al. 1998; Annese et al. 1999; Hampe et al. 1999; Akolkar et al. 2001 ; the IBD In-ternational Genetics Consortium 2001). The IBD1 locus has also been demonstrated to be significantly linked with CD in Jewish families (Cho et al. 1997; Akolkar et al. 2001) . Recently, the IBD1 gene (NOD2/ CARD15) was simultaneously identified by a positionalcloning strategy (Hugot et al. 2001 ) and a positional candidate gene strategy (Hampe et al. 2001; Ogura et al. 2001a) . The NOD2/CARD15 molecule is expressed primarily in monocytes and activates NF-kB through interaction with its N-terminal caspase recruitment domains (CARDs) (Ogura et al. 2001b ). Three coding polymorphisms or variants (R702W, G908R, and 1007fs, denoted elsewhere as SNP8, 12, and 13, respectively; Hugot et al. 2001) in NOD2/CARD15 were shown to be independently associated with CD (Hugot et al. 2001) , with the most significant evidence for 1007fs, which results in a frameshift in the 10th leucine-rich repeat and is followed by a premature stop codon. This truncation mutation in the NOD2/CARD15 molecule appears to result in an inability to activate NF-kB in response to bacterial lipopolysaccharides (Ogura et al. 2001a) . All three of these disease-predisposing mutations (DPMs) are found on the same background haplotype, which can be identified by several other SNPs, including P268S (denoted elsewhere as SNP5; Hugot et al. 2001) . However, an average of 60%-70% of patients with CD do not have any of the three NOD2/ CARD15 DPMs (Abreu et al. 2002; Ahmad et al. 2002; Cuthbert et al. 2002; Hampe et al. 2002b; Lesage et al. 2002; Vermeire et al. 2002) . These three predisposing mutations do not account for all of the linkage between CD and the IBD1 locus, since residual evidence of linkage in the region is observed after families with the variants are removed (Hugot et al. 2001; Hampe 2002a) .
Because of the unique evolutionary history of the Ashkenazi Jewish population (Motulsky 1979 (Motulsky , 1995 , one might expect that the genes predisposing to CD in the Jewish population would be more homogeneous than those in the general white population (Diamond and Rotter 2002) . A study of the Ashkenazi Jewish population with high incidence of CD should yield increased power and more specific haplotype information to identify genetic variants that are associated with CD, in a manner analogous to the specific BRCA1 and BRCA2 mutations occurring in the Jewish population (Struewing et al. 1997; Moslehi et al. 2000) . Thus, to determine if additional DPMs exist at the IBD1 locus in the highrisk Jewish group, we first tested if there was remaining evidence for linkage after excluding the influence of the three known causative mutations (702W, 908R, and 1007fs). We then examined the association between CD and the known causative mutations and a background variant. Significant association of CD with a background haplotype in the Jewish population then led us to sequence the translated region of NOD2/CARD15 to identify additional DPMs in this gene. These studies resulted in identification of a new haplotype for NOD2/ CARD15 that is a major factor predisposing to CD in Ashkenazi Jews.
Subjects and Methods

Study Subjects
A total of 211 families with CD (64 Ashkenazi-Jewish and 147 non-Jewish white families) were studied, consisting of 373 patients with CD and 672 unaffected relatives. The probands of all families were ascertained from the IBD Center at Cedars-Sinai Medical Center or referred to us by gastroenterologists or the Crohn's Colitis Foundation of America nationwide. These families have at least one family member affected with CD and do not have any known individuals affected with ulcerative colitis. In these 211 families, 91 multiplex families with CD that included sib pairs with CD were available for linkage analysis (28 Ashkenazi-Jewish and 63 nonJewish families). In addition, an independent case-control panel (112 Ashkenazi-Jewish and 166 non-Jewish patients with CD and 79 Ashkenazi-Jewish and 143 nonJewish control individuals) was also included in this study. Controls were recruited from spouses, married-in relatives, or acquaintances who had no known IBD or other autoimmune diseases or family history of IBD. The present study, as a part of an ongoing IBD genetic study, was reviewed and approved by the Human Subject Institutional Review Board at Cedars-Sinai Medical Center.
Genotyping and Sequencing Analysis
To conduct the linkage study, we genotyped six microsatellite markers spanning the IBD1 locus, covering 34 cM on chromosome 16 (D16S403, D16S753, D16S409, D16S411, D16S419, and D16S408) using an ABI 377 automated DNA analyzer and associated software (Applied Biosystems). For association analysis of NOD2/ CARD15, we genotyped all families with CD and casecontrol samples for SNPs, including the three principal DPMs (R702W, G908R, and 1007fs), one background SNP (P268S), and a new SNP (IVS8ϩ158 [CrT], JW1), identified by us after sequencing (see below), by the Taqman MGB bialleic discrimination system using an ABI 7900 instrument (Applied Biosystems).
All the sequenced individuals ( ) were of Ash-N p 12 kenazi Jewish origin. DNA sequences of NOD2/CARD15 exons, including the 5 UTR and splicing signal regions, were analyzed, according to the protocol of the Big Dye Terminator Ready Reaction kits (Applied Biosystems). Sequencing primers were the same as PCR primers except for exon 9, in which nested primers were used (table 1) . Sequence data were analyzed on an ABI 377 DNA ana- lyzer with associated software, and alignments were performed using BioEdit.
Statistical Analysis
Two-point nonparametric linkage analyses were performed separately by use of SIBPAL from the Statistical Analysis for Genetic Epidemiology (SAGE) version 3.1 package on the Jewish and non-Jewish multiplex families. Family-based association was evaluated by a transmission/disequilibrium test (TDT) (Spielman et al. 1993) in all families with CD. Since only 29% of the families were multiplex families, and there was no difference in the TDT results between simplex and multiplex families, we report the results from all families combined. To perform the TDT, GENEHUNTER2 (Kruglyak et al. 1996) was used for four-locus SNP haplotypes, and SIMWALK2 (Sobel and Lange 1996) was used to construct haplotypes for five SNPs. In the case-control samples, PHASE was used to construct haplotypes (Stephens et al. 2001) . Haplotypic genotype frequencies were compared between case and control individuals, using the x 2 test. Odds ratio (OR) and its 95% CI were calculated for each risk haplotype, referenced to the same low-risk haplotype by the Mantel-Haenszel method (Schlesselman 1982) . Population-attributable risk (PAR) was estimated under the assumption that the frequency of a risk haplotype in the control group can be regarded as approximately representative of the target population and the OR as an approximation of the relative risk. Thus, PAR p , where Pe p frequency Pe(OR Ϫ 1)/[Pe(OR Ϫ 1) ϩ 1] of a risk haplotype in the control group (Schlesselman 1982) .
Results
Stratified Linkage Analysis on the NOD2/CARD15 Genotype
When the families were analyzed in each ethnic group, we found a trend toward increased mean allele sharing (MAS) at markers D16S403 (31 Mb from NOD2/ CARD15, MAS 0.55, ) and D16S411 (1.8 Mb P p .11 from NOD2/CARD15, MAS 0.54, ) in the Jew-P p .20 ish families with CD. In the non-Jewish families with CD, increased MASs (10.50) were observed at all marker positions, with the peak at marker D16S411 (MAS 0.56, ), but they did not attain statistical significance P p .094 in this sample size.
When we divided the Jewish families into NOD2/ CARD15 DPMsϩ and CARD15 DPMsϪ subgroups on the basis of the possession of any of the three principal DPMs in the family, the evidence for linkage in families DPMϪ for NOD2/CARD15 increased and reached a significant level, with the two peaks at marker D16S403 ( , ) at proximal 16p and at MAS p 0.70 P p .0008 marker D16S411 ( , ) at proximal MAS p 0.59 P p .1 16q near NOD2/CARD15 ( fig. 1 ). In contrast, in the non-Jewish families with CD, the significantly increased MAS was observed only in families DPMϩ for NOD2/ CARD15 (the highest at D16S411, MAS p 0.61 P p ), whereas there was no evidence for any MAS .0075 increase in families DPMϪ for NOD2/CARD15 ( ) ( fig. 1) . These results indicated a MAS p 0.47-0.52 different contribution of the three known DPMs to the IBD1 linkage of CD between the two ethnic groups and raised the possibility that additional predisposing gene(s) or additional NOD2/CARD15 DPM(s) exist at the IBD1 locus and play a more important role in the sus- a The haplotypes 702W, 908R, and 1007fs represent the haplotype that has the rare variant of each mutation. All 702W, 908R, and 1007fs haplotypes also possess the rare variant of the background SNP (268S).
Figure 1
MAS in multiplex families with Crohn disease before and after stratification on presence or absence of three principal NOD2/ CARD15 DPMs (702W, 908R, and 1007fs). Six microsatellite markers spanning NOD2/CARD15 locus on chromosome 16 were genotyped (from left to right, D16S403, D16S753, D16S409, D16S411, D16S419, and D16S408, respectively). Left panel, Jewish families. Right panel, non-Jewish families. Black circles represent the MAS from entire families (prestratification) in each ethnic group. White triangles represent the MASs in the families where there are no principal NOD2/CARD15 DPMs, and white squares represent the MASs in families with principal NOD2/CARD15 DPMs, after stratification. ceptibility to CD in the Jewish population when compared with the non-Jewish population.
TDT
We performed the family-based association test (using the TDT method) to investigate any ethnic differences of the CD association with the three known NOD2/ CARD15 DPMs. We observed that all the 702W, 908R, or 1007fs variants almost always (98%) occur on a common background haplotype, which contains the 268S variant, and that the 702W, 908R, and 1007fs variants were never found on the same haplotype in both family groups.
In the non-Jewish families, there were very significant associations with 702W (transmitted/not transmitted [T/ NT]: 42/11, ) and 1007fs (T/NT: 34/12, P p .000021 ), and there was also an increased frequency P p .0012 of transmission with 908R (T/NT: 10/6), but this was not statistically significant (table 2) . Although the number of families was moderate, we did observe a significant association between CD and the 908R haplotype (T/NT: 13/2, ) in the Jewish families. Mean-P p .0045 while, the association of the 1007fs and of the 702W variants to CD was not observed. Furthermore, there appeared to be a preferential transmission of the haplotype with only the background variant (268S) in Jewish (T/NT: 8/5) but not in non-Jewish families (T/NT: 31/38), though this excess in Jews did not attain statistical significance. Although the lack of association with certain DPMs in Jewish families and preferential transmission of 268S alone could be due to the small sample size, the apparent ethnic difference in allele transmission led us to test these DPMs further in a larger ethnically matched case-control sample.
Case-Control Study
We examined haplotypic genotypes in an independent Jewish and non-Jewish case-control panel. Because of small numbers in rare allele homozygotes and compound heterozygotes, we combined the rare allele homozygotes with heterozygotes and also lumped all other rare haplotypes together so that six main haplotypic groups were formed (table 3) .
In comparable sample sizes, we observed a significant association between the haplotype with the frameshift mutation (1007fs) and CD in both the Jewish (OR p , ) and non-Jewish samples ( 7.50 P p .0041 OR p , ) (combined ). Increases of the 3.54 P p .024 P ! .001 908R haplotype were seen in both ethnic groups, although the association did not attain statistical significance in the non-Jewish group, probably because of low frequency of this haplotype in the non-Jewish population. With regard to the 702W haplotype, we observed a significant association with CD ( , OR p 2.50 P p ) in the non-Jewish population only. In the Jewish .022 population, the association of the 702W haplotype did not reach statistical significance, although an increased OR was observed , ). (OR p 2.00 P p .24 It was intriguing that we observed a highly significant association between the haplotype carrying only the background variant (268S alone haplotype) and CD in the Jewish sample ( , ) but no ev-OR p 3.13 P p .0023 idence for association of this haplotype in non-Jews ( , ). These data indicated that the OR p 1.06 P p .834 268S alone haplotype predisposes to risk for CD in Jews and might contain an as-yet-unrecognized predisposing mutation(s).
Sequence Analysis
To search for possible unrecognized mutation(s) on the 268S alone haplotype in Jews, we sequenced the NOD2/CARD15 exons, including the 5 UTR and splicing-signal regions in 12 Jewish individuals. These consisted of seven patients with CD with the 268S-alone haplotype (CD1-CD7; fig. 2 ), three patients (CD8-CD10), and two normal control individuals (NC1 and NC2) without the 268S variant. We found 12 sequence variants, 10 identified elsewhere and 2 newly identified variants, namely intervening sequence (IVS) (a 8 ϩ 158 variant of this SNP is denoted as "JW1") and R791Q. The is a CrT mutation in the palindrome IVS8 ϩ 158 sequence in the intron 8 splicing region, and R791Q is a GrA nonsynonymous mutation in exon 4, causing an amino acid substitution of arginine to glutamine. We did not find any nonsynonymous mutation commonly possessed by Jewish patients with CD with the 268S-alone haplotype. Figure 2 shows the position of these variants in the 12 sequenced individuals. Nine of the 12 variants were found in the Jewish patients with the 268S-alone haplotype. The most common variant observed in those patients was IVS10-133 (SNP9). In addition, 5 UTR-59 (rs2076752), S178S (rs2067085), R459R (SNP6), R587R (SNP7), R791Q, IVS8ϩ158 (JW1), V955I, and IVS10ϩ64 (rs1077861) were also observed.
Genotyping of the IVS8ϩ158 (JW1)
Of the nine variants observed in the patients with the 268S-alone haplotype, the only common variant not documented elsewhere was the newly identified IVS8ϩ158 (JW1). We therefore genotyped this JW1 variant as a possible DPM or as a marker identifying a disease-predisposing haplotype. Since the available sample size in the Jewish families was limited, we utilized the casecontrol panel to investigate the role of the JW1 variant.
This JW1 variant also showed linkage disequilibrium (LD) with other reported DPMs. In the Jewish population, all the 1007fs or 702W variants occurred on the same haplotype as JW1. In contrast, the 908R variant occurred on the haplotype that did not possess JW1 ( fig. 3 ). This trend was similarly observed in the non-Jewish groups. Meanwhile, the 268S-alone haplotype was divided into two haplotype groups on the basis of the possession of
Figure 2
NOD2/CARD15 polymorphisms observed in P268S-alone haplotypes in Ashkenazi Jewish patients with CD. CD1 and CD2 are homozygous patients with the P268S rare allele without known three DPMs (702W, 908R, and 1007fs). CD3-CD7 are heterozygous patients with 268S without the three DPMs. CD8-CD10 are patients and NC1 and NC2 are normal control individuals without any of four variants (268S and three DPMs). IVS p Intervening sequences; 1 p Common allele; 2 p Rare allele.
Figure 3
Haplotype structure of the five NOD2/CARD15 variants genotyped in this study. The letters in white squares indicate the variant (rare allele) of each SNP. The capital letters S, W, and R represent the amino acid variants serine, tryptophan, and arginine, respectively. The small letter t represents the nucleotide variant thymine at the JW1 SNP, and fs represents the frameshift mutation at the 1007fs SNP.
the JW1 variant in both ethnic groups. The new JW1 variant is located telomeric to P268S SNP and is almost always accompanied by the 268S variant (272/283 p ) similar to the other three principal DPMs.
96%
In this haplotypic-genotype analysis, we observed a strong association of the 268S-JW1 haplotype (without the three known DPMs) with CD in Jews, independent of the other DPM haplotype groups (table 4). Comparing within the 268S-alone haplotype group, the 268S-JW1 haplotype showed a remarkably increased association ( ), and the most significant P value OR p 5.75 ( ) among all DPM haplotype groups in the P p .0005 Jewish population. Furthermore, the 268S-JW1 group in the Ashkenazi Jews showed the highest populationattributable risk (PAR, 15.1%) among all DPM groups ( fig. 4) . When the 268S-JW1 haplotype was taken into account, the population-attributable risk of NOD2/ CARD15 risk variants in Ashkenazi Jews became 28.3%, which was double the PAR of the three DPMs observed in non-Jewish whites (14.6%).
The 268S-JW1(Ϫ) haplotype did not show any disease association in the Jewish population. In addition, in the non-Jewish population, we did not find any association with either the 268S-JW1(ϩ) haplotype (CD 15.6% vs. control 15.3%) or the 268S-JW1(Ϫ) haplotype (6.6% vs. 11.1%).
A phylogenetic tree of NOD2/CARD15 haplotypes comprising five genotyped SNPs (P268S, R702W, G908R, 1007fs, and IVS8ϩ158[JW1]) was constructed with the use of CLUSTALW (Thompson et al. 1994; fig. 5 ). In this tree, the 908R haplotype forms a separate branch, whereas haplotypes of 268S-JW1, 1007fs, and 702W compose a related group characterized by the possession of the JW1 variant. However, in the JW1 group, the 702W haplotype hardly contributed to the risk of CD in the Jewish patients ( ); conversely, the 268S-PAR p 0.8% JW1 haplotype hardly contributed to the risk of CD in the non-Jewish patients ( ). Therefore, we PAR p 0.3% did not delineate a common ancestral haplotype representing the susceptibility to CD in both ethnic groups. NOTE.-The 268S-JW1 and 268S-JW1(Ϫ) groups are the two subgroups of the "268S Alone" group in table 3, defined by presence or absence of the JW1 rare variant. The association was tested in comparison with the "Reference" group, as defined in table 3.
a Each haplotype group under "five-SNP-locus haplotype" consists of individuals with the following haplotypic genotype. Each SNP position is P268S, R702W, G908R, JW1, and 1007fs, respectively. "1" means wild type; "2" is the rare variant of the SNP. This seems to suggest that an additional causative factor exists on the 268S-JW1 haplotype in the Jewish population.
Discussion
We report the delineation of a novel haplotype (268S-JW1) for the susceptibility to CD in the Ashkenazi Jewish population at the IBD1 locus on chromosome 16. Although we did not find a new common nonsynonymous variant of NOD2/CARD15 on this haplotype, 268S-JW1 appeared to contribute predominantly to the risk of CD in Jews, as it presented the highest population-attributable risk (15.1%) among NOD2/CARD15 variants in the Jewish population. This observation indicates that JW1 is a variant that identifies an unrecognized predisposing factor(s) to CD in the Jewish population. This factor(s) may account for some of the increased susceptibility to CD in the Jewish population.
The JW1 variant reported here is located in the palindrome sequence in intron 8; we could not identify any new common coding mutation in NOD2/CARD15 on this 268S-JW1 haplotype. Hence, there is a possibility that this variant may affect the expression and function of the NOD2/CARD15 molecule. But we found neither signal sequences nor promoter sequence homology with the JW1 sequence, and there was no preserved sequence between human and mouse species around the JW1 variation (WWW Signal Scan; WWW Promoter Scan; UCSC Genome Bioinformatics). We also checked the splicing of intron 8 in JW1 homozygous mononuclear cells, comparing with control cells without the JW1 mutation, yet we did not find any change of splicing length in intron 8 (data not shown). Further, in the non-Jewish population, we did not observe an association of the 268S-JW1 haplotype with CD. Therefore, these available data argue that the JW1 variant alone does not have a pathologic effect directly, but it more likely occurs in strong LD with a population-specific causative factor in Jews.
Additional strategies will be required to identify the Jewish-specific causative factor to elucidate the mechanisms of the high incidence and prevalence of CD in the Jewish population.
In the Jewish families with CD who did not carry any known NOD2/CARD15 DPMs, we observed the strongest evidence for linkage at marker D16S403 and an increased mean allele sharing at marker D16S411, close to NOD2/CARD15. This phenomenon was not observed in the non-Jewish population. These results indicate that the relative extent of contribution of the three known principal DPMs to the IBD1 linkage to CD is different among ethnic groups, and imply the existence of additional responsible haplotype(s) specific for CD in the Jewish population.
The possible existence of population-specific responsible factors and/or haplotypes other than known principal DPMs in NOD2/CARD15 has been recently re-
Figure 5
The phylogenetic tree of five haplotypes generated by using CLUSTALW (a multiple alignments and tree-making program). This tree indicates the relationships between the CD-associated haplotypes in both Jewish and non-Jewish populations and a possible haplotype development consisting of five genotyped SNPs (P268S, R702W, G908R, 1007fs, and IVS8ϩ158 [JW1]).
ported by Hampe and his colleagues (2002a) . After excluding the influence of the known NOD2/CARD15 DPMs in German families with CD, they still observed strong linkage for CD at marker D16S3068 in proximal 16p and at marker D16S3019 in central 16q and weak linkage at marker D16S409 in proximal 16q. The marker D16S3068 is located between D16S403 and D16S753 in our study, and marker D16S409 is located 2.8 Mb centromeric to NOD2/CARD15. In addition, Hampe et al. also observed an ethnic difference between German and British families, as there was no remaining linkage in British families with CD after the influence of known DPMs was excluded. Our linkage results in Jewish families were quite in accord with their observations and support the existence of additional population-specific responsible factors and/or haplotypes on chromosome 16.
The NOD2/CARD15 association with CD has been observed in many populations (but not in all), such as lack of association of the 908R variant in Norwegians (haplotype frequency: CD 0.86%, control 1.2%) (Hampe et al. 2002b ) and the 908R variant in the Dutch population (allele frequency: CD 4.3%, control 3.0%) (Murillo et al. 2002) . We did not observe a significant association between 702W and CD in both family and case-control studies in the Jewish population. These ethnic differences in the association of NOD2/CARD15 DPMs may be explained by the limited sample size or by the low haplotype and allele frequencies in these populations. Or this difference could imply that the positive association and linkage of these DPMs (908R and/or 702W) to CD is based on LD between a common unknown causative factor on their haplotypes and these variants. However, as we did not identify a common ancestral haplotype between Jewish and non-Jewish populations ( fig. 5) , an additional causative factor seems to exist on the 268S-JW1 haplotype in the Jewish population.
In conclusion, we found a novel NOD2/CARD15 haplotype (268S-JW1) in Ashkenazi Jews to be strongly associated with CD, and this haplotype appeared to contribute to the higher incidence and prevalence of CD in this population. Furthermore, we observed evidence for the possible existence of a population-specific disease causative factor(s) at the IBD1 locus and the possibility of the ethnic-specific additional linkage on the short arm of chromosome 16 in Ashkenazi Jewish patients with CD. Further studies on this novel susceptible NOD2/ CARD15 haplotype (268S-JW1) should lead to the identification of additional as-yet-unrecognized predisposing factor(s) to CD and contribute to our understanding of the underlying mechanism of the linkage of IBD1 to CD. This study was supported by the National Institutes of Health grants DK54967 and DK46763, General Clinical Research Center grant RR00425, and the Cedars-Sinai Board of Governors' Chair in Medical Genetics. Some of the results of this article were obtained by using the SAGE program, which is supported by a United States Public Health Service Resource grant (1 P41 RR03655) from the National Center for Research Resources. 
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